Physiological Approach for Coronary Artery Bifurcation Disease: Position Statement by Korean, Japanese, and European Bifurcation Clubs

Hak Seung Lee; Ung Kim; Seokhun Yang; Yoshinobu Murasato; Yves Louvard; Young Bin Song; Takashi Kubo; Thomas W Johnson; Soon Jun Hong; Hiroyuki Omori; Manuel Pan; Joon-Hyung Doh; Yoshihisa Kinoshita; Adrian P Banning; Chang-Wook Nam; Junya Shite; Thierry Lefèvre; Hyeon-Cheol Gwon; Yutaka Hikichi; Yiannis S Chatzizisis; Jens Flensted Lassen; Goran Stankovic; Bon-Kwon Koo

doi:10.1016/j.jcin.2022.05.002

Physiological Approach for Coronary Artery Bifurcation Disease: Position Statement by Korean, Japanese, and European Bifurcation Clubs

Hak Seung Lee, Ung Kim, Seokhun Yang, Yoshinobu Murasato, Yves Louvard, Young Bin Song, Takashi Kubo, Thomas W Johnson, Soon Jun Hong, Hiroyuki Omori, Manuel Pan, Joon-Hyung Doh, Yoshihisa Kinoshita, Adrian P Banning, Chang-Wook Nam, Junya Shite, Thierry Lefèvre, Hyeon-Cheol Gwon, Yutaka Hikichi, Yiannis S ChatzizisisJens Flensted Lassen, Goran Stankovic, Bon-Kwon Koo

Bristol Medical School (THS)

Research output: Contribution to journal › Review article (Academic Journal) › peer-review

9 Citations (Scopus)

Abstract

Coronary artery bifurcation lesions are frequently encountered in cardiac catheterization laboratories and are associated with more complex procedures and worse clinical outcomes than nonbifurcation lesions. Therefore, anatomical and physiological assessment of bifurcation lesions before, during, and after percutaneous coronary intervention is of paramount clinical importance. Physiological assessment can help interventionalists appreciate the hemodynamic significance of coronary artery disease and guide ischemia-directed revascularization. However, it is important to understand that the physiological approach for bifurcation disease is more important than simply using physiological indexes for its assessment. This joint consensus document by the Korean, Japanese, and European bifurcation clubs presents the concept of a physiological approach for coronary bifurcation lesions, as well as current knowledge, practical tips, pitfalls, and future directions of applying physiological indexes in bifurcation percutaneous coronary intervention. This document aims to guide interventionalists in performing appropriate physiology-based assessments and treatment decisions for coronary bifurcation lesions.

Original language	English
Pages (from-to)	1297-1309
Number of pages	13
Journal	JACC: Cardiovascular Interventions
Volume	15
Issue number	13
Early online date	15 May 2022
DOIs	https://doi.org/10.1016/j.jcin.2022.05.002
Publication status	Published - 11 Jul 2022

Bibliographical note

Funding Information:
Dr Pan has received minor lecture fees from Abbott and Philips. Dr Banning has received institutional funding of a fellowship from Boston Scientific; and has received speaker fees from Boston Scientific, Abbott, Medtronic, Philips/Volcano, and Miracor. Dr Johnson has received consultancy and speaker fees from Abbott Vascular, Boston Scientific, and Terumo; and has received institutional funding for fellowships from Boston Scientific and Terumo. Dr Lefèvre has received speaker and proctorship fees from Abbott, Boston Scientific, Terumo, and Edwards Lifesciences. Dr Chatzizisis has received speaker honoraria, advisory board fees, and research grant support from Boston Scientific; and has received advisory board fees and research grant support from Medtronic. Dr Lassen has received speaker fees from Medtronic, Boston Scientific, Biotronik, Abbott, and Biosensors. Dr Stankovic has received speaker fees from Medtronic, Abbott, Boston Scientific, and Terumo. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Publisher Copyright:
© 2022 American College of Cardiology Foundation

Keywords

Coronary Angiography
Coronary Artery Disease/diagnostic imaging
Humans
Japan
Percutaneous Coronary Intervention/adverse effects
Republic of Korea
Treatment Outcome

Access to Document

10.1016/j.jcin.2022.05.002

Handle.net

Persistent link

Cite this

Lee, H. S., Kim, U., Yang, S., Murasato, Y., Louvard, Y., Song, Y. B., Kubo, T., Johnson, T. W., Hong, S. J., Omori, H., Pan, M., Doh, J.-H., Kinoshita, Y., Banning, A. P., Nam, C.-W., Shite, J., Lefèvre, T., Gwon, H.-C., Hikichi, Y., ... Koo, B.-K. (2022). Physiological Approach for Coronary Artery Bifurcation Disease: Position Statement by Korean, Japanese, and European Bifurcation Clubs. JACC: Cardiovascular Interventions, 15(13), 1297-1309. https://doi.org/10.1016/j.jcin.2022.05.002

@article{1938d863780b41338dd76e07bfa6ff63,

title = "Physiological Approach for Coronary Artery Bifurcation Disease: Position Statement by Korean, Japanese, and European Bifurcation Clubs",

abstract = "Coronary artery bifurcation lesions are frequently encountered in cardiac catheterization laboratories and are associated with more complex procedures and worse clinical outcomes than nonbifurcation lesions. Therefore, anatomical and physiological assessment of bifurcation lesions before, during, and after percutaneous coronary intervention is of paramount clinical importance. Physiological assessment can help interventionalists appreciate the hemodynamic significance of coronary artery disease and guide ischemia-directed revascularization. However, it is important to understand that the physiological approach for bifurcation disease is more important than simply using physiological indexes for its assessment. This joint consensus document by the Korean, Japanese, and European bifurcation clubs presents the concept of a physiological approach for coronary bifurcation lesions, as well as current knowledge, practical tips, pitfalls, and future directions of applying physiological indexes in bifurcation percutaneous coronary intervention. This document aims to guide interventionalists in performing appropriate physiology-based assessments and treatment decisions for coronary bifurcation lesions.",

keywords = "Coronary Angiography, Coronary Artery Disease/diagnostic imaging, Humans, Japan, Percutaneous Coronary Intervention/adverse effects, Republic of Korea, Treatment Outcome",

author = "Lee, {Hak Seung} and Ung Kim and Seokhun Yang and Yoshinobu Murasato and Yves Louvard and Song, {Young Bin} and Takashi Kubo and Johnson, {Thomas W} and Hong, {Soon Jun} and Hiroyuki Omori and Manuel Pan and Joon-Hyung Doh and Yoshihisa Kinoshita and Banning, {Adrian P} and Chang-Wook Nam and Junya Shite and Thierry Lef{\`e}vre and Hyeon-Cheol Gwon and Yutaka Hikichi and Chatzizisis, {Yiannis S} and Lassen, {Jens Flensted} and Goran Stankovic and Bon-Kwon Koo",

note = "Funding Information: Dr Pan has received minor lecture fees from Abbott and Philips. Dr Banning has received institutional funding of a fellowship from Boston Scientific; and has received speaker fees from Boston Scientific, Abbott, Medtronic, Philips/Volcano, and Miracor. Dr Johnson has received consultancy and speaker fees from Abbott Vascular, Boston Scientific, and Terumo; and has received institutional funding for fellowships from Boston Scientific and Terumo. Dr Lef{\`e}vre has received speaker and proctorship fees from Abbott, Boston Scientific, Terumo, and Edwards Lifesciences. Dr Chatzizisis has received speaker honoraria, advisory board fees, and research grant support from Boston Scientific; and has received advisory board fees and research grant support from Medtronic. Dr Lassen has received speaker fees from Medtronic, Boston Scientific, Biotronik, Abbott, and Biosensors. Dr Stankovic has received speaker fees from Medtronic, Abbott, Boston Scientific, and Terumo. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Publisher Copyright: {\textcopyright} 2022 American College of Cardiology Foundation",

year = "2022",

month = jul,

day = "11",

doi = "10.1016/j.jcin.2022.05.002",

language = "English",

volume = "15",

pages = "1297--1309",

journal = "JACC: Cardiovascular Interventions",

issn = "1936-8798",

publisher = "Elsevier Inc.",

number = "13",

}

Lee, HS, Kim, U, Yang, S, Murasato, Y, Louvard, Y, Song, YB, Kubo, T, Johnson, TW, Hong, SJ, Omori, H, Pan, M, Doh, J-H, Kinoshita, Y, Banning, AP, Nam, C-W, Shite, J, Lefèvre, T, Gwon, H-C, Hikichi, Y, Chatzizisis, YS, Lassen, JF, Stankovic, G & Koo, B-K 2022, 'Physiological Approach for Coronary Artery Bifurcation Disease: Position Statement by Korean, Japanese, and European Bifurcation Clubs', JACC: Cardiovascular Interventions, vol. 15, no. 13, pp. 1297-1309. https://doi.org/10.1016/j.jcin.2022.05.002

TY - JOUR

T1 - Physiological Approach for Coronary Artery Bifurcation Disease

T2 - Position Statement by Korean, Japanese, and European Bifurcation Clubs

AU - Lee, Hak Seung

AU - Kim, Ung

AU - Yang, Seokhun

AU - Murasato, Yoshinobu

AU - Louvard, Yves

AU - Song, Young Bin

AU - Kubo, Takashi

AU - Johnson, Thomas W

AU - Hong, Soon Jun

AU - Omori, Hiroyuki

AU - Pan, Manuel

AU - Doh, Joon-Hyung

AU - Kinoshita, Yoshihisa

AU - Banning, Adrian P

AU - Nam, Chang-Wook

AU - Shite, Junya

AU - Lefèvre, Thierry

AU - Gwon, Hyeon-Cheol

AU - Hikichi, Yutaka

AU - Chatzizisis, Yiannis S

AU - Lassen, Jens Flensted

AU - Stankovic, Goran

AU - Koo, Bon-Kwon

N1 - Funding Information: Dr Pan has received minor lecture fees from Abbott and Philips. Dr Banning has received institutional funding of a fellowship from Boston Scientific; and has received speaker fees from Boston Scientific, Abbott, Medtronic, Philips/Volcano, and Miracor. Dr Johnson has received consultancy and speaker fees from Abbott Vascular, Boston Scientific, and Terumo; and has received institutional funding for fellowships from Boston Scientific and Terumo. Dr Lefèvre has received speaker and proctorship fees from Abbott, Boston Scientific, Terumo, and Edwards Lifesciences. Dr Chatzizisis has received speaker honoraria, advisory board fees, and research grant support from Boston Scientific; and has received advisory board fees and research grant support from Medtronic. Dr Lassen has received speaker fees from Medtronic, Boston Scientific, Biotronik, Abbott, and Biosensors. Dr Stankovic has received speaker fees from Medtronic, Abbott, Boston Scientific, and Terumo. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Publisher Copyright: © 2022 American College of Cardiology Foundation

PY - 2022/7/11

Y1 - 2022/7/11

N2 - Coronary artery bifurcation lesions are frequently encountered in cardiac catheterization laboratories and are associated with more complex procedures and worse clinical outcomes than nonbifurcation lesions. Therefore, anatomical and physiological assessment of bifurcation lesions before, during, and after percutaneous coronary intervention is of paramount clinical importance. Physiological assessment can help interventionalists appreciate the hemodynamic significance of coronary artery disease and guide ischemia-directed revascularization. However, it is important to understand that the physiological approach for bifurcation disease is more important than simply using physiological indexes for its assessment. This joint consensus document by the Korean, Japanese, and European bifurcation clubs presents the concept of a physiological approach for coronary bifurcation lesions, as well as current knowledge, practical tips, pitfalls, and future directions of applying physiological indexes in bifurcation percutaneous coronary intervention. This document aims to guide interventionalists in performing appropriate physiology-based assessments and treatment decisions for coronary bifurcation lesions.

AB - Coronary artery bifurcation lesions are frequently encountered in cardiac catheterization laboratories and are associated with more complex procedures and worse clinical outcomes than nonbifurcation lesions. Therefore, anatomical and physiological assessment of bifurcation lesions before, during, and after percutaneous coronary intervention is of paramount clinical importance. Physiological assessment can help interventionalists appreciate the hemodynamic significance of coronary artery disease and guide ischemia-directed revascularization. However, it is important to understand that the physiological approach for bifurcation disease is more important than simply using physiological indexes for its assessment. This joint consensus document by the Korean, Japanese, and European bifurcation clubs presents the concept of a physiological approach for coronary bifurcation lesions, as well as current knowledge, practical tips, pitfalls, and future directions of applying physiological indexes in bifurcation percutaneous coronary intervention. This document aims to guide interventionalists in performing appropriate physiology-based assessments and treatment decisions for coronary bifurcation lesions.

KW - Coronary Angiography

KW - Coronary Artery Disease/diagnostic imaging

KW - Humans

KW - Japan

KW - Percutaneous Coronary Intervention/adverse effects

KW - Republic of Korea

KW - Treatment Outcome

U2 - 10.1016/j.jcin.2022.05.002

DO - 10.1016/j.jcin.2022.05.002

M3 - Review article (Academic Journal)

C2 - 35717395

SN - 1936-8798

VL - 15

SP - 1297

EP - 1309

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

IS - 13

ER -